April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 29, 2025

Progression in Parkinson’s

α-Synuclein PET tracer shows potential to diagnose and monitor the disease

The Pathologist

April 29, 2025

Obesity Independently Hinders Remission in RA

Study shows BMI above 30 correlates with poorer treatment outcomes regardless of comorbidities

Conexiant

April 29, 2025

Nerve Blocks Compared for Knee Replacement

This 2025 analysis of 6 randomized controlled trials found femoral triangle block (FTB) provided better pain relief during activity at 48 hours post-TKA compared to adductor canal block (ACB), while ACB better preserved quadriceps muscle strength.

Conexiant

April 29, 2025

Pediatric Concussion Recovery Takes Months

"Most children reach optimal functioning within 3 to 6 months; this information should be included in anticipatory guidance and reassurance to families."

Conexiant

April 28, 2025

High Dose Vitamin D May Reduce MS Activity

Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.

Conexiant

April 28, 2025

One Third Report HPPD After Psychedelics

Delusional ideation was found to be reduced one month after psychedelic use, researchers reported in a prospective cohort of 654 participants.

Conexiant

April 28, 2025

Can Lower Blood Pressure Prevent Dementia?

‘Intensive BP reduction is effective in lowering the risk of all-cause dementia,’ a large trial finds

Conexiant

April 28, 2025

High Dose Vitamin D May Reduce MS Activity

Vitamin D significantly reduced disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis in the D-Lay MS trial.

Conexiant